On July 14, 2024, the company announced that its Board of Directors will consider a proposal for share repurchase program at its Board Meeting to be held on July 18, 2024. Under the program, the company will repurchase its own shares.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,370 INR | -0.36% |
|
+2.81% | +26.37% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.37% | 9.64B | |
+63.05% | 856B | |
+38.95% | 631B | |
-4.78% | 359B | |
+17.52% | 325B | |
+8.43% | 297B | |
+13.63% | 244B | |
+4.79% | 234B | |
+16.13% | 226B | |
+14.63% | 177B |
- Stock Market
- Equities
- AUROPHARMA Stock
- News Aurobindo Pharma
- Aurobindo Pharma Limited's Board intends to launch an Equity Buyback on July 18, 2024.